Regenerative Medicine Foundation
  • Leadership
  • What We Do
    • Policy
    • Advocacy
    • Education & Outreach
  • Events
    • Regenerative Medicine Essentials
    • World Stem Cell Summit
    • Exploring Public Policy: Regenerative Medicine and Cell Therapies
    • Congressional Briefings
    • Regenerative Medicine and Stem Cell Action Awards
    • World Stem Cell Summit – CHINA
  • Membership/Register
    • Membership – Register for WSCS and RME Course
    • Donate
    • Amazon SMILE
  • News
    • News
    • Portraits of Hope
    • Video
    • Video Chats
  • Contact
Select Page

California’s Stem Cell Agency Invests in Phase 3 Clinical Trial to Help Kidney Transplant Patients

by Kevin McMahon | Jan 18, 2018 | News & Opinions

January 18, 2018 – Oakland, CA Over 650,000 Americans suffer from end-stage kidney disease – a life-threatening condition caused by the loss of kidney function. The best available treatment for these patients is a kidney transplant from a genetically...

Recent Posts

  • Human mesenchymal stem cells show promise in treating chronic lung infections
  • Longeveron Selected to Present at the 2021 World Stem Cell Summit Dr. Joshua Hare, Longeveron’s Chief Science Officer, to present during this year’s Longevity Session
  • Breakthrough Paper Outlines Path to Heart Regeneration After Cardiac Injury
  • Advancing the Development of Safe and Effective Regenerative Medicine Products
  • Clinical trial assesses stem cells’ ability to prevent major cause of preemie deaths
Tweets about @WSCSummit
CC Regenerative Medicine Foundation